Wednesday, October 14, 2026
Via News Knowledge File

Amazon.com Inc.

organization100% conf.·synced Oct 14, 2026

E-commerce and technology company

60
sourced metrics
2243
relationships
20
stated objectives
8
Via News reports

Every fact below is drawn from Via News's knowledge graph and linked to the source document it came from. Nothing here is unsourced. How we source →

Key metrics · each point sourced

Market Cap
2789124963448USD
Oct 13, 2026reference only
Stock Price
258.58USD
Oct 13, 2026reference only
Price 52 Week High
284.02USD
Oct 13, 2026reference only
Price 52 Week Low
198.79USD
Oct 13, 2026reference only
Stock Return Ytd
14.2%
Oct 13, 2026reference only
Shares Outstanding
10786313572.0shares
Jul 22, 2026reference only
Revenue
200606000000.0USD
Jun 30, 2026reference only
Stockholders Equity
551620000000.0USD
Jun 30, 2026reference only
Eps
5.75USD_per_share
Jun 30, 2026reference only
Operating Cash Flow
45387000000.0USD
Jun 30, 2026reference only
Total Assets
1095689000000.0USD
Jun 30, 2026reference only
Operating Income
27461000000.0USD
Jun 30, 2026reference only
Net Income
62647000000.0USD
Jun 30, 2026reference only
Cost Of Revenue
95778000000.0USD
Jun 30, 2026reference only
Cash
78213000000.0USD
Jun 30, 2026reference only

Stated objectives

Increase sales through Catalog AI implementation

source
target: 7.5 billion USD by 2025-01-01 00:00:00stated

Support SMR development with projects expected to come online in early 2030s

source
stated

Invest over $300 billion in AI opportunity

source
target: 300 billion USD by 2025-01-01 00:00:00stated

Capital expenditure plan for AI infrastructure build-out

source
target: 200 billion USD by 2026-12-31 00:00:00stated

Reduce layers, increase ownership, and reduce bureaucracy through workforce reduction

source
target: 16000 employees eliminated stated

Focus on delivery services and expand Whole Foods instead of Amazon Fresh/Go stores

source
stated

Achieve net-zero emissions

source
target: net-zero by 2030-01-01 00:00:00stated

Demand logistics facilities operational in six months

source
target: 6 months to operation stated

Secure and deliver significant AI capacity over the next several years through AWS

source
stated

Reduce layers, increase ownership, and reduce bureaucracy through workforce cuts

source
target: 16000 employees stated

Relationship graph · 2243 connections

Competes with
511
Supplies to
240
Invested in
231
Developed by
201
subsidiary of
178
Customer of
167
Covered by
140
Employs
91

Via News coverage

This Knowledge File is assembled from Via News's source-traceable knowledge graph. Metrics, objectives and relationships are extracted from primary and credible secondary documents and refreshed on a schedule. Read our methodology →
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,375 source documents archived
Query this data → isubstrate.com